Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical study

Acid ceramidase-mediated production of sphingosine 1-phosphate promotes prostate cancer invasion through upregulation of cathepsin B

(2012) Thomas H. Beckham et al.   INTERNATIONAL JOURNAL OF CANCER

Hepatocellular carcinoma

(2012) Alejandro Forner et al.   LANCET

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

(2011) Elisabeth Luporsi et al.   BREAST CANCER RESEARCH AND TREATMENT

Cathepsin B cleavable novel prodrug Ac-Phe-Lys-PABC-ADM enhances efficacy at reduced toxicity in treating gastric cancer peritoneal carcinomatosis

(2011) Li-Hua Shao et al.   CANCER

Cathepsin B promotes the progression of pancreatic ductal adenocarcinoma in mice

(2011) Aarthi Gopinathan et al.   GUT

Systemic Treatment of Hepatocellular Carcinoma: Dawn of a New Era?

(2010) Andrew X. Zhu   ANNALS OF SURGICAL ONCOLOGY

Knowledge of Hepatocellular Carcinoma Screening Guidelines and Clinical Practices Among Gastroenterologists

(2010) Pratima Sharma et al.   DIGESTIVE DISEASES AND SCIENCES

High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma

(2010) X.-R. Yang et al.   GUT

Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science

(2010) Shinji Tanaka et al.   International Journal of Clinical Oncology

Sunitinib in Patients with Advanced Hepatocellular Carcinoma after Progression under Sorafenib Treatment

(2010) Marcus Alexander Wörns et al.   ONCOLOGY

Current approach in the treatment of hepatocellular carcinoma

(2010) Luigi Rossi   World Journal of Gastrointestinal Oncology

Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study

(2009) D M Berney et al.   BRITISH JOURNAL OF CANCER

Angiogenesis in liver cirrhosis and hepatocellular carcinoma

(2009) AnjaliD Amarapurkar et al.   Indian Journal of Pathology and Microbiology

Proteomic Expression Signature Distinguishes Cancerous and Nonmalignant Tissues in Hepatocellular Carcinoma

(2009) Nikki P. Lee et al.   JOURNAL OF PROTEOME RESEARCH

Distinction of hepatocellular adenoma from hepatocellular carcinoma with and without cirrhosis using E-cadherin and matrix metalloproteinase immunohistochemistry

(2009) Maria S Tretiakova et al.   MODERN PATHOLOGY

Molecular targeted therapies in hepatocellular carcinoma

(2008) Josep M. Llovet et al.   HEPATOLOGY

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

(2008) Ann-Lii Cheng et al.   LANCET ONCOLOGY

Evolving Strategies for the Management of Hand-Foot Skin Reaction Associated with the Multitargeted Kinase Inhibitors Sorafenib and Sunitinib

(2008) M. E. Lacouture et al.   ONCOLOGIST